Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer : Prospective Cohort Comparing the Recommandation for Patient Care According to the Immunoscore® With the Standard Care Decision.

Evaluate the patient care recommandation induced by the IMMUNOSCORE® result

Inclusion Criteria:

• age between 18 and 80 inclusive;
• histologically confirmed colon adenocarcinoma;
• having undergone a curative resection of stage I, II or III colorectal cancer;
• diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;
• eligible to receive 6 months of adjuvant chemotherapy;
• having given free, informed and written consent;
• agreeing to the use of a tumor sample for research purposes;
• being affiliated to a social security system.

Exclusion Criteria:

• pregnant or breastfeeding women
• legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study.
• history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled
• person subject to a safeguard measure.